Your browser doesn't support javascript.
loading
Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial.
Bobb, Jennifer F; Idu, Abisola E; Qiu, Hongxiang; Yu, Onchee; Boudreau, Denise M; Wartko, Paige D; Matthews, Abigail G; McCormack, Jennifer; Lee, Amy K; Campbell, Cynthia I; Saxon, Andrew J; Liu, David S; Altschuler, Andrea; Samet, Jeffrey H; Northrup, Thomas F; Braciszewski, Jordan M; Murphy, Mark T; Arnsten, Julia H; Cunningham, Chinazo O; Horigian, Viviana E; Szapocznik, José; Glass, Joseph E; Caldeiro, Ryan M; Tsui, Judith I; Burganowski, Rachael P; Weinstein, Zoe M; Murphy, Sean M; Hyun, Noorie; Bradley, Katharine A.
Afiliação
  • Bobb JF; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA. Electronic address: jennifer.f.bobb@kp.org.
  • Idu AE; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
  • Qiu H; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
  • Yu O; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
  • Boudreau DM; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
  • Wartko PD; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
  • Matthews AG; The Emmes Company, 401 N Washington St, Suite 700, Rockville, MD 20850, USA.
  • McCormack J; The Emmes Company, 401 N Washington St, Suite 700, Rockville, MD 20850, USA.
  • Lee AK; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
  • Campbell CI; Kaiser Permanente Northern California Division of Research, 2000 Broadway, Oakland, CA 94612, USA.
  • Saxon AJ; Center of Excellence in Substance Addiction Treatment and Education (CESATE), VA Puget Sound Health Care System, 1660 S. Columbian Way, Seattle, WA 98108, USA.
  • Liu DS; National Institute on Drug Abuse Center for Clinical Trials Network, Three White Flint North, 11601 Landsdown Street, North Bethesda, MD 20852, USA.
  • Altschuler A; Kaiser Permanente Northern California Division of Research, 2000 Broadway, Oakland, CA 94612, USA.
  • Samet JH; Boston University Schools of Medicine and Public Health, Boston Medical Center, Crosstown Center, 801 Massachusetts Ave, Boston, MA 02119, USA.
  • Northrup TF; UTHealth Houston McGovern Medical School, Department of Family and Community Medicine, 6431 Fannin St, Houston, TX 77030, USA.
  • Braciszewski JM; Henry Ford Health, Center for Health Policy and Health Services Research, One Ford Place, Suite 5E, Detroit, MI 48202, USA.
  • Murphy MT; MultiCare Health System, 315 Martin Luther King Jr. Way, Tacoma, WA 98415, USA.
  • Arnsten JH; Montefiore Medical Center, 111 East 210 Street, Bronx, NY 10467, USA; Albert Einstein College of Medicine, 1300 Morris Park Ave, The Bronx, NY 10461, USA.
  • Cunningham CO; Albert Einstein College of Medicine, 1300 Morris Park Ave, The Bronx, NY 10461, USA.
  • Horigian VE; Department of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14th Street, 10th Floor, Miami, FL 33136, USA.
  • Szapocznik J; Department of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14th Street, 10th Floor, Miami, FL 33136, USA.
  • Glass JE; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
  • Caldeiro RM; Mental Health and Wellness Department, Kaiser Permanente Washington, 1200 SW 27th St, Renton, WA 98057, USA.
  • Tsui JI; Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, 1959 NE Pacific St, Seattle, WA 98195, USA.
  • Burganowski RP; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
  • Weinstein ZM; Boston University Schools of Medicine and Public Health, Boston Medical Center, Crosstown Center, 801 Massachusetts Ave, Boston, MA 02119, USA.
  • Murphy SM; Department of Population Health Sciences, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA.
  • Hyun N; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
  • Bradley KA; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
Drug Alcohol Depend ; 261: 111350, 2024 Aug 01.
Article em En | MEDLINE | ID: mdl-38875880
ABSTRACT

BACKGROUND:

Patients with opioid use disorder (OUD) have increased emergency and hospital utilization. The PROUD trial showed that implementation of office-based addiction treatment (OBAT) increased OUD medication treatment compared to usual care, but did not decrease acute care utilization in patients with OUD documented pre-randomization (clinicaltrials.gov/study/NCT03407638). This paper reports secondary emergency and hospital utilization outcomes in patients with documented OUD in the PROUD trial.

METHODS:

This cluster-randomized implementation trial was conducted in 12 clinics from 6 diverse health systems (March 2015-February 2020). Patients who visited trial clinics and had an OUD diagnosis within 3 years pre-randomization were included in primary analyses; secondary analyses added patients with OUD who were new to the clinic or with newly-documented OUD post-randomization. Outcomes included days of emergency care and hospital utilization over 2 years post-randomization. Explanatory outcomes included measures of OUD treatment. Patient-level analyses used mixed-effect regression with clinic-specific random intercepts.

RESULTS:

Among 1988 patients with documented OUD seen pre-randomization (mean age 49, 53 % female), days of emergency care or hospitalization did not differ between intervention and usual care; OUD treatment also did not differ. In secondary analyses among 1347 patients with OUD post-randomization, there remained no difference in emergency or hospital utilization despite intervention patients receiving 32.2 (95 % CI 4.7, 59.7) more days of OUD treatment relative to usual care.

CONCLUSIONS:

Implementation of OBAT did not reduce emergency or hospital utilization among patients with OUD, even in the sample with OUD first documented post-randomization in whom the intervention increased treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atenção Primária à Saúde / Serviço Hospitalar de Emergência / Transtornos Relacionados ao Uso de Opioides Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atenção Primária à Saúde / Serviço Hospitalar de Emergência / Transtornos Relacionados ao Uso de Opioides Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024